Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review
Authors:
Open Access
- 4 February 2023
- journal article
- case report
- Published by Springer Nature in Diagnostic Pathology
- Vol. 18 (1) , 1-8
Abstract
Background: Mucinous cystadenocarcinoma (MCA) is a very rare form of breast cancer that was first described in 1998. Only 33 cases of primary MCA, including our present case, have been reported thus far. As a consequence, its molecular features, prognosis and treatment regimen are poorly known. Here, we describe a less common presentation of MCA, detail its molecular features, discuss the major differential diagnosis, and provide a brief review of the literature. Case presentation: A 59-year-old woman presented with a breast lump in which mammography showed a well-defined nodule. Core needle biopsy (CNB) revealed several lesions lined by tall columnar cells with stratification and abundant mucinous secretion; excision was recommended for final diagnosis. The resected specimens showed cavities of different sizes without surrounding myoepithelial cells. The cavities were rich in mucus, and the nuclei were located at the base of the cells, containing intracellular mucus. Immunohistochemical analysis revealed that it was triple-negative breast cancer (TNBC). Next-generation sequencing (NGS) revealed pathogenic mutations in the PIK3CA, KRAS, MAP2K4, RB1, KDR, PKHD1, TERT, and TP53 genes. A diagnosis of MCA was rendered. The patient has been followed up for 108 months to date and showed no signs of recurrence or metastasis. Conclusion: Our study presents the gene profile of an MCA case with no recurrence or metastatic tendency after 108 months of follow-up, and a review of the literature helps us better understand the clinical, pathologic, and molecular features of this tumor.Keywords
Funding Information
- Changzhou Science and Technology Project (QN202114)
This publication has 42 references indexed in Scilit:
- Mucinous cystadenocarcinoma of the breast with a basal‐like immunophenotypePathology International, 2012
- Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancerBreast Cancer Research, 2012
- Primary mammary mucinous cystadenocarcinoma: Cytological and histological findingsDiagnostic Cytopathology, 2011
- Mucinous cystadenocarcinoma: A rare primary malignant tumor of the breastIndian Journal of Pathology and Microbiology, 2010
- Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell linesBreast Cancer Research and Treatment, 2009
- Mucinous Cystadenocarcinoma of the Breast with Estrogen Receptor Expression: A Case Report and Review of the LiteratureCase Reports in Oncology, 2009
- Mucinous metaplasia of breast carcinoma with macrocystic transformation resembling ovarian mucinous cystadenocarcinoma in a case of synchronous bilateral infiltrating ductal carcinomaPathology International, 2008
- Mammary mucinous cystadenocarcinomaHistopathology, 2006
- Mucinous cystadenocarcinoma of the breast coexisting with infiltrating ductal carcinomaPathology International, 2004
- Cystic hypersecretory duct carcinoma of the breastAmerican Journal of Surgical Pathology, 1984